Devraj Basu
Papers
1
Total Citations
2
H-Index
1
About
Devraj Basu is a leading surgical oncologist whose research focuses on the de-intensification of treatment for HPV-related oropharyngeal cancers, particularly through the integration of transoral robotic surgery (TORS). His work addresses a critical challenge in head and neck oncology: reducing the long-term toxicity of therapy without compromising oncologic outcomes. Basu’s most-cited study, a Phase II trial published in 2022, demonstrated that carefully selected patients with p16+ oropharyngeal squamous cell carcinoma could safely undergo volume and dose de-intensification following TORS and neck dissection. This landmark contribution has helped shift the paradigm toward more personalized, function-preserving care, offering patients a lower burden of radiation and chemotherapy. While his citation count is still growing, the clinical impact of his work is already evident in evolving treatment guidelines and surgical protocols. Basu’s research bridges the gap between surgical innovation and radiation oncology, providing a roadmap for future trials that aim to maintain high cure rates while minimizing treatment-related morbidity. His ongoing investigations continue to refine patient selection criteria and expand the role of minimally invasive surgery in de-escalation strategies.
Research Focus
Key Achievements
Top Papers
- 1